Sports Medicine

, Volume 38, Issue 11, pp 931–946 | Cite as

Physiological Responses of Sickle Cell Trait Carriers during Exercise

  • Philippe Connes
  • Harvey Reid
  • Marie-Dominique Hardy-Dessources
  • Errol Morrison
  • Olivier Hue
Review Article

Abstract

Growing evidence suggests that physiological responses during exercise in sickle cell trait (SCT) carriers might differ from persons with normal haemoglobin. Epidemiological and experimental results support the view that SCT carriers could be advantaged in certain anaerobic activities, but the underlying physiological and bio-cellular mechanisms remain unknown. Maximal aerobic physical fitness (i.e. maximal oxygen consumption and maximal aerobic power) is not affected by SCT; however, recent studies suggest that SCT carriers could be characterized by a lesser aerobic capacity. Discrepancies are frequently reported in the literature concerning lactate metabolism during exercise in this population. While some studies observed higher blood lactate concentration during exercise in individuals carrying SCT compared with subjects with normal haemoglobin, others described lower concentration, which suggests a paradoxical lower lactate production by exercising muscles and/or greater ability to clear circulating lactate in SCT carriers. One of the most debated topics is the clinically benign condition of SCT, particularly during strenuous exercise. SCT carriers are usually involved in physical exercise without developing medical complications; however, several authors have presented case reports of SCT carriers who have collapsed and died unexpectedly during or after exercise. Blood rheological, haemostatic and vascular adhesion mechanism abnormalities in combination with environmental factors, such as heat strain, might play a role in the occurrence of these fatal scenarios. Several physiological differences have been observed between SCT carriers and non-SCT carriers, which make it necessary to consider the former as a specific population in response to exercise.

Notes

Acknowledgements

No sources of funding were used in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

References

  1. 1.
    Korubo-Owiye T. Frequency distribution of haemoglobin genotypes in the Niger-delta of Nigeria. J Expr Clin Sci 1993; 1: 47–50Google Scholar
  2. 2.
    Mitchell BL. Sickle cell trait and sudden death: bringing it home. J Natl Med Assoc 2007; 99: 300–5PubMedGoogle Scholar
  3. 3.
    Fabritius H, Millan J, Le Corroller Y. Systematic screening of hemoglobinopathies in blood donors in Guadeloupe(French West Indies) [in French]. Rev Fr TransfusImmunohematol 1978; 21: 937–50PubMedGoogle Scholar
  4. 4.
    Steinberg MH. Sickle cell trait. In: Steinberg MH, Forget BG, Higgs DR, et al., editors. Disorders ofhemoglobin: genetics, pathophysiology, and clinical management. Cambridge: Cambridge University Press,2001: 811–30Google Scholar
  5. 5.
    Ashcroft MT, Desai P. Mortality and morbidity in Jamaican adults with sickle-cell trait and with normal hemoglobin followed up for twelve years. Lancet 1976; II: 784–6Google Scholar
  6. 6.
    Jones SR, Binder RA, Donowho Jr EM. Sudden death in sickle-cell trait. N Engl J Med 1970; 282: 323–5PubMedGoogle Scholar
  7. 7.
    Ewing PC. Death of an athlete with sickle cell trait. Med World News 1974; 15: 44Google Scholar
  8. 8.
    Buddington RS, Stahl CJI, McAllister HA, et al. Sports, death, and unusual heart disease [abstract]. Am J Cardiol 1974; 33: 129Google Scholar
  9. 9.
    Zimmerman J, Granatir R, Mummert K, et al. Sickle crisis precipitated by exercise rhabdomyolysis in apatient with sickle cell trait: case report. Mil Med 1974;139: 313–5PubMedGoogle Scholar
  10. 10.
    Spencer JD. Case for diagnosis. Mil Med 1980; 145: 396–405PubMedGoogle Scholar
  11. 11.
    George C. Acute renal failure due to rhabdomyolysis in sickle cell trait. Intensive Care Med 1979; 5: 204–5PubMedGoogle Scholar
  12. 12.
    Helzlsouer KJ, Hayden FG, Rogol AD. Severe metabolic complications in a cross-country runner with sickle cell trait. JAMA 1983; 249: 777–9PubMedGoogle Scholar
  13. 13.
    Davis AM. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 1988; 318: 787PubMedGoogle Scholar
  14. 14.
    Kark JA, Posey DM, Schumacher HR, et al. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 1987; 317: 781–7PubMedGoogle Scholar
  15. 15.
    Kark JA, Ward FT. Exercise and hemoglobin S. Semin Hematol 1994; 31: 181–225PubMedGoogle Scholar
  16. 16.
    Dincer HE, Raza T. Compartment syndrome and fatal rhabdomyolysis in sickle cell trait. WMJ 2005; 104: 67–71PubMedGoogle Scholar
  17. 17.
    Wirthwein DP, Spotswood SD, Barnard JJ, et al. Death due to microvascular occlusion in sickle-cell trait following physical exertion. J Forensic Sci 2001; 46: 399–401PubMedGoogle Scholar
  18. 18.
    Connes P, Hardy-Dessources MD, Hue O. Counterpoint: sickle cell trait should not be considered asymptomaticand as a begin condition during physical activity. J Appl Physiol 2007; 103: 2138–40PubMedGoogle Scholar
  19. 19.
    Le Gallais D, Lonsdorfer J, Bogui P, et al. Point: sickle cell trait should be considered asymptomatic and as a begin condition during physical activity. J Appl Physiol 2007; 103: 2137–8PubMedGoogle Scholar
  20. 20.
    Pearson HA. Sickle cell trait and competitive athletics: is there a risk? Pediatrics 1989; 83: 613–4PubMedGoogle Scholar
  21. 21.
    Caray AL. Genetic and anthropological studies of Olympic athletes. New York: Academic Press, 1974Google Scholar
  22. 22.
    Le Gallais D, Lonsdorfer J, Fabritius H, et al. Prevalence of the sickle cell trait among students in a physical education college in Cote-d’Ivoire. Nouv Rev Fr Hematol 1989; 31: 409–12PubMedGoogle Scholar
  23. 23.
    Thiriet P, Lobe MM, Gweha I, et al. Prevalence of the sickle cell trait in an athletic West African population. Med Sci Sports Exerc 1991; 23: 389–90PubMedGoogle Scholar
  24. 24.
    Le Gallais D, Prefaut C, Dulat C, et al. Sickle cell trait in Ivory Coast athletic champions, 1956-1989. Int J SportsMed 1991; 12: 509–10PubMedGoogle Scholar
  25. 25.
    Le Gallais D, Prefaut C, Mercier J, et al. Sickle cell trait as a limiting factor for high-level performance in asemi-marathon. Int J Sports Med 1994; 15: 399–402PubMedGoogle Scholar
  26. 26.
    Hue O, Julan ME, Blonc S, et al. Alactic anaerobic performance in subjects with sickle cell trait and hemoglobin. Int J Sports Med 2002; 23: 174–7PubMedGoogle Scholar
  27. 27.
    Connes P, Racinais S, Sara F, et al. Does the pattern of repeated sprint ability differ between sickle cell trait carriers and healthy subjects? Int J Sports Med 2006; 27: 937–42PubMedGoogle Scholar
  28. 28.
    Connes P, Monchanin G, Perrey S, et al. Oxygen uptake kinetics during heavy submaximal exercise: effect of sickle cell trait with or without alpha-thalassemia. Int J Sports Med 2006; 27: 517–25PubMedGoogle Scholar
  29. 29.
    Bilé A, Le Gallais D, Mercier B, et al. Anaerobic exercise components during the force-velocity test in sickle cell trait. Int J Sports Med 1996; 17: 254–8PubMedGoogle Scholar
  30. 30.
    Morrison EY, Cooper PD. Some bio-medical mechanisms in athletic prowess. West Indian Med J 2006; 55: 205–9PubMedGoogle Scholar
  31. 31.
    Le Gallais D, Lonsdorfer J, Buguet A, et al. frAptitude physique des porteurs du trait drépanocytaire. Sci Sports 1987; 2: 269–77Google Scholar
  32. 32.
    Bilé A, Le Gallais D, Mercier J, et al. Sickle cell trait in Ivory Coast athletic throw and jump champions, 1956-1995. Int J Sports Med 1998; 19: 215–9PubMedGoogle Scholar
  33. 33.
    Marlin L, Etienne-Julan M, Le Gallais D, et al. Sickle cell trait in French West Indian elite sprint athletes. Int JSports Med 2005; 26: 622–25Google Scholar
  34. 34.
    Le Gallais D, Lonsdorfer J, Bogui P, et al. Trait drépanocytaire (AS) et performances en courses de vitesse derésistance et d‘endurance. Sci Sports 1989; 4: 249–51Google Scholar
  35. 35.
    Green HJ. Muscular adaptations at extreme altitude: metabolic implications during exercise. Int J Sports Med 1992; 13 Suppl. 1: 163–5Google Scholar
  36. 36.
    Mercier J, Mercier B, Prefaut C. Blood lactate increase during the force velocity exercise test. Int J Sports Med 1991; 12: 17–20PubMedGoogle Scholar
  37. 37.
    Jones NL, McCartney N, Graham T, et al. Muscle performance and metabolism in maximal isokinetic cycling at slow and fast speeds. J Appl Physiol 1985; 59: 132–6PubMedGoogle Scholar
  38. 38.
    Davies CT, Young K. Effects of external loading on short term power output in children and young male adults. Eur J Appl Physiol Occup Physiol 1984; 52: 351–4PubMedGoogle Scholar
  39. 39.
    Bishop D, Spencer M, Duffield R, et al. The validity of a repeated sprint ability test. J Sci Med Sport 2001; 4: 19–29PubMedGoogle Scholar
  40. 40.
    McGawley K, Bishop D. Reliability of a 5. 6–s maximal cycling repeated-sprint test in trained female team-sportathletes. Eur J Appl Physiol 2006; 98: 383–93PubMedGoogle Scholar
  41. 41.
    Gozal D, Thiriet P, Mbala E, et al. Effect of different modalities of exercise and recovery on exercise performancein subjects with sickle cell trait. Med Sci Sports Exerc 1992; 24: 1325–31PubMedGoogle Scholar
  42. 42.
    Murphy JR. Sickle cell hemoglobin (Hb AS) in black football players. JAMA 1973; 225: 981–2PubMedGoogle Scholar
  43. 43.
    Diggs LW, Flowers E. High school athletes with the sickle cell trait (Hb A/S). J Natl Med Assoc 1976; 68: 492–3PubMedGoogle Scholar
  44. 44.
    Thiriet P, Le Hesran JY, Wouassi D, et al. Sickle cell trait performance in a prolonged race at high altitude. Med Sci Sports Exerc 1994; 26: 914–8PubMedGoogle Scholar
  45. 45.
    Embury SH. The interaction of alpha-thalassemia with sickle cell anemia. Hemoglobin 1988; 12: 509–17PubMedGoogle Scholar
  46. 46.
    Monchanin G, Connes P, Wouassi D, et al. Hemorheology, sickle cell trait, and alpha-thalassemia in athletes: effectsof exercise. Med Sci Sports Exerc 2005; 37: 1086–92PubMedGoogle Scholar
  47. 47.
    Becklake MR, Griffiths SB, Mc GM, et al. Oxygen dissociation curves in sickle cell anemia and in subjects withthe sickle cell trait. J Clin Invest 1955; 34: 751–5PubMedGoogle Scholar
  48. 48.
    Reid HL, Obi GO. A study of erythrocyte deformability in sickle cell disease. Trop Geogr Med 1982; 34: 43–6PubMedGoogle Scholar
  49. 49.
    Ambrus JL, Bannerman RM, Sills RH, et al. Studies on the vasoocclusive crisis of sickle cell disease, III. In vitroand in vivo effect of the pyrimido-pyrimidine derivative,RA-233: studies on its mechanism of action. J Med 1987; 18: 165–98PubMedGoogle Scholar
  50. 50.
    Obiefuna PC. Rouleaux formation in sickle cell traits. J Trop Med Hyg 1991; 94: 42–4PubMedGoogle Scholar
  51. 51.
    Brandao MM, Fontes A, Barjas-Castro ML, et al. Optical tweezers for measuring red blood cell elasticity: application to the study of drug response in sickle cell disease. Eur J Haematol 2003; 70: 207–11PubMedGoogle Scholar
  52. 52.
    Connes P, Sara F, Hardy-Dessources MD, et al. Does higher red blood cell (RBC) lactate transporter activity explain impaired RBC deformability in sickle cell trait? J Physiol 2005; 55: 385–7Google Scholar
  53. 53.
    Connes P, Sara F, Hardy-Dessources MD, et al. Effects of short supramaximal exercise on hemorheology insickle cell trait carriers. Eur J Appl Physiol 2006; 97 (2): 143–50PubMedGoogle Scholar
  54. 54.
    McHedlishvili G. Disturbed blood flow structuring as critical factor of hemorheological disorders in microcirculation. Clin Hemorheol Microcirc 1998; 19: 315–25PubMedGoogle Scholar
  55. 55.
    Parthasarathi K, Lipowsky HH. Capillary recruitment in response to tissue hypoxia and its dependenceon red blood cell deformability. Am J Physiol 1999; 277: 2145–57Google Scholar
  56. 56.
    Connes P, Yalcin O, Baskurt O, et al. In health and in a normoxic environment,VO2max is/is not limited primarilyby cardiac output and locomotor muscle blood flow[letter]. J Appl Physiol 2006; 100: 2099PubMedGoogle Scholar
  57. 57.
    Brun JF, Fons C, Supparo C, et al. Could exercise-induced increase in blood viscosity at high shear rate be entirelyexplained by hematocrit and plasma viscosity changes? Clin Hemorheol 1993; 13 (2): 187–99Google Scholar
  58. 58.
    Brun JF, Khaled S, Raynaud E, et al. The triphasic effects of exercise on blood rheology: which relevance to physiologyand pathophysiology? Clin Hemorheol Microcirc 1998; 19: 89–104PubMedGoogle Scholar
  59. 59.
    Cresta M. Energy expenditure in sicklemia [letter]. JAMA 1974; 228: 287PubMedGoogle Scholar
  60. 60.
    Robinson JR, Stone WJ, Asendorf AC. Exercise capacity of black sickle cell trait males. Med Sci Sports 1976; 8: 244–5PubMedGoogle Scholar
  61. 61.
    Nuss R, Loehr JP, Daberkow E, et al. Cardiopulmonary function in men with sickle cell trait who resideat moderately high altitude. J Lab Clin Med 1993; 122: 382–7PubMedGoogle Scholar
  62. 62.
    Weisman IM, Zeballos RJ, Martin TW, et al. Effect of army basic training in sickle-cell trait. Arch Intern Med 1988; 148: 1140–4PubMedGoogle Scholar
  63. 63.
    Weisman IM, Zeballos RJ, Johnson BD. Effect of moderate inspiratory hypoxia on exercise performance in sicklecell trait. Am J Med 1988; 84: 1033–40PubMedGoogle Scholar
  64. 64.
    Weisman IM, Zeballos RJ, Johnson BD. Cardiopulmonary and gas exchange responses to acute strenuous exerciseat 1,270 meters in sickle cell trait. Am J Med 1988; 84: 377–83PubMedGoogle Scholar
  65. 65.
    Martin TW, Weisman IM, Zeballos RJ, et al. Exercise and hypoxia increase sickling in venous blood from anexercising limb in individuals with sickle cell trait. Am J Med 1989; 87: 48–56PubMedGoogle Scholar
  66. 66.
    Hardy RE, Mukherjee S, Hinds JE, et al. Effects of physical stress on complete blood count and venous blood gasprofile of individuals with sickle cell trait. Acta Haematol 1992; 88: 114–9PubMedGoogle Scholar
  67. 67.
    Sara F, Hardy-Dessources MD, Voltaire B, et al. Lactic response in sickle cell trait carriers in comparison withsubjects with normal hemoglobin. Clin J Sport Med 2003; 13: 96–101PubMedGoogle Scholar
  68. 68.
    Sara F, Hardy-Dessources MD, Marlin L, et al. Lactate distribution in the blood compartments of sickle cell traitcarriers during incremental exercise and recovery. Int J Sports Med 2006; 27: 436–43PubMedGoogle Scholar
  69. 69.
    Bilé A, Le Gallais D, Mercier B, et al. Blood lactate concentrations during incremental exercise in subjectswith sickle cell trait. Med Sci Sports Exerc 1998;30: 649–54PubMedGoogle Scholar
  70. 70.
    Marlin L, Sara F, Antoine-Jonville S, et al. Ventilatory and lactic thresholds in subjects with sickle cell trait. Int J Sports Med 2007; 28: 916–20PubMedGoogle Scholar
  71. 71.
    Marlin L, Connes P, Antoine-Jonville S, et al. Cardiorespiratory responses during three repeated incrementalexercise tests in sickle cell trait carriers. Eur J Appl Physiol 2008; 102: 181–7PubMedGoogle Scholar
  72. 72.
    Poiseuille JLM. frRecherches sur les causes du mouvement du sang dans les vaisseaux capillaires. C R Acad Sci Paris 1835; 1: 554–60Google Scholar
  73. 73.
    Freund H, Lonsdorfer J, Oyono-Enguelle S, et al. Lactate exchange and removal abilities in sickle cell trait carriersduring and after incremental exercise. Int J Sports Med 1995; 16: 428–34PubMedGoogle Scholar
  74. 74.
    Sara F, Connes P, Hue O, et al. Faster lactate transport across red blood cell membrane in sickle cell trait carriers. J Appl Physiol 2006; 100: 437–42Google Scholar
  75. 75.
    Lonsdorfer J, Bogui P, Boutros-Toni F, et al. Physiopathologie cardio-respiratoire dans les hémoglobinopathiesà Hb S. Med Trop 1986; 22: 31–46Google Scholar
  76. 76.
    Ashcroft MT, Desai P, Richardson SA, et al. Growth, behaviour, and educational achievement of Jamaican children with sickle-cell trait. BMJ 1976; 1: 1371–3PubMedGoogle Scholar
  77. 77.
    Rehan N. Growth status of children with and without sickle cell trait. Clin Pediatr (Phila) 1981; 20: 705–9Google Scholar
  78. 78.
    Gupta AK, Kirchner KA, Nicholson R, et al. Effects of alpha-thalassemia and sickle polymerization tendency onthe urine-concentrating defect of individuals with sicklecell trait. J Clin Invest 1991; 88: 1963–8PubMedGoogle Scholar
  79. 79.
    Heller P, Best WR, Nelson RB, et al. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenasedeficiency in hospitalized black male patients. N Engl J Med 1979; 300: 1001–5PubMedGoogle Scholar
  80. 80.
    Davis Jr CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 1995; 19: 1–11PubMedGoogle Scholar
  81. 81.
    Sears DA. The morbidity of sickle cell trait: a review of the literature. Am J Med 1978; 64: 1021–36PubMedGoogle Scholar
  82. 82.
    Miller Jr JM. Sickle cell trait in pregnancy. South Med J 1983; 76: 962–3PubMedGoogle Scholar
  83. 83.
    Michelson PE, Pfaffenbach D. Retinal arterial occlusion following ocular trauma in youths with sickle-traithemoglobinopathy.Am J Ophthalmol 1972; 74: 494–7PubMedGoogle Scholar
  84. 84.
    Goldberg MF. The diagnosis and treatment of secondary glaucoma after hyphema in sickle cell patients. Am J Ophthalmol 1979; 87: 43–9PubMedGoogle Scholar
  85. 85.
    Wolf A, Shalem M, Horowitz J, et al. Retinal vascular occlusion following traumatic hyphema and glaucoma, as a presenting sign of sickle cell trait. Isr Med Assoc J 2005; 7: 476–7PubMedGoogle Scholar
  86. 86.
    Malhotra V, Prakash R, Choi YS, et al. Fatal pulmonary infarction in a patient with sickle trait. Chest 1973; 64: 524–6PubMedGoogle Scholar
  87. 87.
    Ebong WW. Avascular necrosis of the femoral head associated with haemoglobinopathy. Trop Geogr Med 1977;29: 19–23PubMedGoogle Scholar
  88. 88.
    Jadavji T, Prober CG. Dactylitis in a child with sickle cell trait. CMAJ 1985; 132: 814–5Google Scholar
  89. 89.
    Taylor PW, Thorpe WP, Trueblood MC. Osteonecrosis in sickle cell trait. J Rheumatol 1986; 13: 643–6PubMedGoogle Scholar
  90. 90.
    Dowling MM. Sickle cell trait is not a risk factor for stroke. Arch Neurol 2005; 62: 1780–1PubMedGoogle Scholar
  91. 91.
    Golomb MR. Sickle cell trait is a risk factor for early stroke. Arch Neurol 2005; 62: 1778–9PubMedGoogle Scholar
  92. 92.
    Steen RG, Hankins GM, Xiong X, et al. Prospective brain imaging evaluation of children with sickle cell trait: initial observations. Radiology 2003; 228: 208–15PubMedGoogle Scholar
  93. 93.
    Connes P, Martin C, Barthelemy JC, et al. Nocturnal autonomic nervous system activity impairment in sickle cell trait carriers. Clin Physiol Funct Imaging 2006; 26: 87–91PubMedGoogle Scholar
  94. 94.
    Connes P, Hue O, Hardy-Dessources MD, et al. Hemorheology and heart rate variability: is there a relationship? Clin Hemorheol Microcirc 2008; 38: 257–65PubMedGoogle Scholar
  95. 95.
    Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement,physiological interpretation and clinical use. Circulation 1996; 93: 1043–65Google Scholar
  96. 96.
    Rahimi Z, Merat A, Haghshenass M, et al. Plasma lipids in Iranians with sickle cell disease: hypocholesterolemiain sickle cell anemia and increase of HDL-cholesterol insickle cell trait. Clin Chim Acta 2006; 365: 217–20PubMedGoogle Scholar
  97. 97.
    Ould Amar AK, Pi Gibert A, Darmon O, et al. AS heterozygote hemoglobinopathy and coronary risk [inFrench]. Arch Mal Coeur Vaiss 1999; 92: 1727–32PubMedGoogle Scholar
  98. 98.
    Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007; 110: 908–12PubMedGoogle Scholar
  99. 99.
    Westerman MP, Green D, Gilman-Sachs A, et al. Coagulation changes in individuals with sickle cell trait. Am JHematol 2002; 69: 89–94Google Scholar
  100. 100.
    Ajayi AA, Kolawole BA. Sickle cell trait and gender influence type 2 diabetic complications in African patients. Eur J Intern Med 2004; 15: 312–5PubMedGoogle Scholar
  101. 101.
    Bencaiova G, Krafft A, Zimmermann R. Is the sickle cell trait a risk factor in patients with type 2 diabetes mellitus?[letter]. Eur J Intern Med 2005; 16: 462PubMedGoogle Scholar
  102. 102.
    Reid HL, Oli JM. The possible significance of abnormal blood rheology in diabetics with sickle-cell trait (HbAS). West Afr J Med 1986; 5: 249–56Google Scholar
  103. 103.
    Oli JM, Reid HL. Do Nigerian diabetics with haemoglobin genotype Hb AS have greater risks of developing renalcomplications and hypertensio4n? A preliminary report. Trop Geogr Med 1985; 37: 309–13PubMedGoogle Scholar
  104. 104.
    Biedrzycki O, Gillespie H, Lucas S. Sudden death in a patient newly diagnosed with diabetes having hyperosmolarnon-ketotic acidosis with sickle cell trait J Clin Pathol 2006; 59: 882–3PubMedGoogle Scholar
  105. 105.
    Reid HL, Famodu AA. Spectrophotometric quantitation of haemoglobin S fraction in heterozygous sickle-celltrait (HbAS). Med Lab Sci 1988; 45: 143–5PubMedGoogle Scholar
  106. 106.
    Baskurt OK, Meiselman HJ, Bergeron MF. Re. point: counterpoint. Sickle cell trait should/should not be consideredasymptomatic and as a benign condition during physical activity. J Appl Physiol 2007; 103 (6): 2142;author reply 2143PubMedGoogle Scholar
  107. 107.
    Koppes GM, Daly JJ, Coltman Jr CA, et al. Exertioninduced rhabdomyolysis with acute renal failure anddisseminated intravascular coagulation in sickle cell trait. Am J Med 1977; 63: 313–7PubMedGoogle Scholar
  108. 108.
    Hynd RF, Bharadwaja K, Mitas JA, et al. Rhabdomyolysis, acute renal failure, and disseminated intravascularcoagulation in a man with sickle cell trait. South Med J 1985; 78: 890–1PubMedGoogle Scholar
  109. 109.
    Sarteriale M, Hart P. Unexpected death in a black military recruit with sickle cell trait: case report. Mil Med 1985;150: 602–5Google Scholar
  110. 110.
    Rosenthal MA, Parker DJ. Collapse of a young athlete. Ann Emerg Med 1992; 21: 1493–8PubMedGoogle Scholar
  111. 111.
    Le Gallais D, Bile A, Mercier J, et al. Exercise-induced death in sickle cell trait: role of aging, training,and deconditioning. Med Sci Sports Exerc 1996; 28: 541–4PubMedGoogle Scholar
  112. 112.
    Kerle KK, Nishimura KD. Exertional collapse and sudden death associated with sickle cell trait. Am Fam Physician 1996; 54: 237–40PubMedGoogle Scholar
  113. 113.
    Gardner JW, Kark JA. Fatal rhabdomyolysis presenting as mild heat illness in military training. Mil Med 1994; 159: 160–3PubMedGoogle Scholar
  114. 114.
    Thogmartin JR. Sudden death in police pursuit. J Forensic Sci 1998; 43: 1228–31PubMedGoogle Scholar
  115. 115.
    NATA. Consensus statement: sickle cell trait and the athlete [online]. Available from URL: http://www.nata.org/statements/consensus/sicklecell.pdf [Accessed 2007Jun 21]
  116. 116.
    Makaryus JN, Catanzaro JN, Katona KC. Exertional rhabdomyolysis and renal failure in patients with sickle cell trait: is it time to change our approach? Hematology 2007; 12: 349–52PubMedGoogle Scholar
  117. 117.
    Ajayi AA. Should the sickle cell trait be reclassified as a disease state? Eur J Intern Med 2005; 16: 463PubMedGoogle Scholar
  118. 118.
    Lucas S. The morbid anatomy of sickle cell disease and sickle cell trait. In: Okpala I, editor. Practical managementof haemoglobinopathies. Oxford: Blackwell Publishing Ltd, 2004Google Scholar
  119. 119.
    Murray MJ, Evans P. Sudden exertional death in a soldier with sickle cell trait. Mil Med 1996; 161: 303–5PubMedGoogle Scholar
  120. 120.
    Sherry P. Sickle cell trait and rhabdomyolysis: case report and review of the literature. Mil Med 1990; 155: 59–61PubMedGoogle Scholar
  121. 121.
    Dudley Jr AW, Waddell CC. Crisis in sickle cell trait. Hum Pathol 1991; 22: 616–8PubMedGoogle Scholar
  122. 122.
    Charache S. Sudden death in sickle trait. Am J Med 1988; 84: 459–61PubMedGoogle Scholar
  123. 123.
    Chien S, Usami S, Bertles JF. Abnormal rheology of oxygenated blood in sickle cell anemia. J Clin Invest 1970; 49: 623–34PubMedGoogle Scholar
  124. 124.
    Gordon PA, Breeze GR, Mann JR, et al. Coagulation fibrinolysis in sickle-cell disease. J Clin Pathol 1974; 27: 485–9PubMedGoogle Scholar
  125. 125.
    Famodu AA. Plasma fibrinolytic activity in sickle cell disease. Trop Geogr Med 1988; 40: 331–3PubMedGoogle Scholar
  126. 126.
    Nash GB, Boghossian S, Parmar J, et al. Alteration of the mechanical properties of sickle cells by repetitive deoxygenation:role of calcium and the effects of calciumblockers. Br J Haematol 1989; 72: 260–4PubMedGoogle Scholar
  127. 127.
    Kaul DK, Nagel RL. Sickle cell vasoocclusion: many issues and some answers. Experientia 1993; 49: 5–15PubMedGoogle Scholar
  128. 128.
    Nsiri B, Gritli N, Bayoudh F, et al. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease. Hematol Cell Ther 1996; 38: 279–84PubMedGoogle Scholar
  129. 129.
    Nsiri B, Gritli N, Mazigh C, et al. Fibrinolytic response to venous occlusion in patients with homozygous sickle celldisease. Hematol Cell Ther 1997; 39: 229–32PubMedGoogle Scholar
  130. 130.
    Ballas SK, Mohandas N. Sickle red cell microrheology and sickle blood rheology. Microcirculation 2004; 11: 209–25PubMedGoogle Scholar
  131. 131.
    Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004; 364: 1343–60PubMedGoogle Scholar
  132. 132.
    Okpala I. Leukocyte adhesion and the pathophysiology of sickle cell disease. Curr Opin Hematol 2006; 13: 40–4PubMedGoogle Scholar
  133. 133.
    Awodu OA, Famodu AA. Haemostatic variables and their relationship to body mass index and blood pressure inadult Nigerians with the sickle cell trait. Clin Hemorheol Microcirc 2007; 36: 89–94PubMedGoogle Scholar
  134. 134.
    Connes P, Tripette J, Chalabi T, et al. Effects of strenuous exercise on blood coagulation activity in sickle cell traitcarriers. Clin Hemorheol Microcirc 2008; 38: 13–21PubMedGoogle Scholar
  135. 135.
    Duits AJ, Pieters RC, Saleh AW, et al. Enhanced levels of soluble VCAM-1 in sickle cell patients and their specificincrement during vasoocclusive crisis. Clin Immunol Immunopathol 1996; 81: 96–8PubMedGoogle Scholar
  136. 136.
    Monchanin G, Serpero LD, Connes P, et al. Effects of a progressive and maximal exercise on plasma levels of adhesion molecules in athletes with sickle cell traitwith or without a-thalassemia. J Appl Physiol 2007; 102: 169–73PubMedGoogle Scholar
  137. 137.
    Tripette J, Connes P, Hedreville M, et al. Patterns of exercise-related inflammatory response in sickle cell traitcarriers. Br J Sports Med. In pressGoogle Scholar
  138. 138.
    Tripette J, Hardy-Dessources MD, Sara F, et al. Does repeated and heavy exercise impair blood rheology incarriers of sickle cell trait? Clin J Sport Med 2007; 17: 465–70PubMedGoogle Scholar
  139. 139.
    Senturk UK, Yalcin O, Gunduz F, et al. Effect of antioxidant vitamin treatment on the time course of hematologicaland hemorheological alterations after an exhaustingexercise episode in human subjects. J Appl Physiol 2005; 98: 1272–9PubMedGoogle Scholar
  140. 140.
    Bergeron MF, Cannon JG, Hall EL, et al. Erythrocyte sickling during exercise and thermal stress. Clin J Sport Med 2004; 14: 354–6PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  • Philippe Connes
    • 1
  • Harvey Reid
    • 2
  • Marie-Dominique Hardy-Dessources
    • 3
  • Errol Morrison
    • 4
  • Olivier Hue
    • 1
  1. 1.Laboratory ACTES UPRES-EA 3596, Department of PhysiologyUniversity of the French West IndiesPointe-à-PitreFrench West Indies
  2. 2.Department of Basic Medical Sciences (Physiology Section), Faculty of Medical SciencesUniversity of the West IndiesMonaJamaica, West Indies
  3. 3.Inserm, U763University of the French West IndiesPointe-à-PitreFrench West Indies
  4. 4.University of TechnologyJamaicaJamaica, West Indies

Personalised recommendations